18.20
+16.47(+952.02%)
Currency In USD
| Previous Close | 1.73 |
| Open | 1.68 |
| Day High | 18.2 |
| Day Low | 1.68 |
| 52-Week High | 82.9 |
| 52-Week Low | 1.68 |
| Volume | 437,523 |
| Average Volume | 17,983 |
| Market Cap | 60.84M |
| PE | -1.08 |
| EPS | -16.8 |
| Moving Average 50 Days | 14.92 |
| Moving Average 200 Days | 16.09 |
| Change | 16.47 |
If you invested $1000 in Reneo Pharmaceuticals, Inc. (RPHM) since IPO date, it would be worth $121.33 as of April 29, 2025 at a share price of $18.2. Whereas If you bought $1000 worth of Reneo Pharmaceuticals, Inc. (RPHM) shares 3 years ago, it would be worth $784.48 as of April 29, 2025 at a share price of $18.2.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Data not available
OnKure Announces Closing of Merger with Reneo Pharmaceuticals and Concurrent Private Placement of $65 Million
GlobeNewswire Inc.
Oct 04, 2024 8:57 PM GMT
-- OnKure is focused on advancing a pipeline of candidates targeting oncogenic mutations in phosphoinositide 3-kinase alpha (PI3Kα), initially in breast cancer -- On track to announce early clinical data for its lead program, OKI-219, in Q4-2024 -- P
Reneo Pharmaceuticals Announces Stockholder Approval of Merger with OnKure
GlobeNewswire Inc.
Oct 03, 2024 12:20 AM GMT
– Combined company to trade on Nasdaq under ticker “OKUR” – Reneo announces 1-for-10 reverse split of common stock IRVINE, Calif., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM) (“Reneo”) today announced the results of